Kevin Sullivan

Kevin Sullivan is a journalist at Tortoise Media, known for his unique perspective on current events and ability to engage readers with thought-provoking content. His work often focuses on topics such as health, politics, and culture in the United States. Sullivan has a talent for uncovering hidden stories and bringing them to light through his writing. He is dedicated to providing accurate information while also challenging readers to think critically about the issues facing society today.

Biography:  https://www.tortoisemedia.com/contributor/kevin-sullivan

96%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

88%

Examples:

  • The author uses exaggerated language to describe the effects of Ozempic, such as

Conflicts of Interest

100%

Examples:

  • There are no clear conflicts of interest identified in the article.

Contradictions

80%

Examples:

  • The author mentions both the positive effects of Ozempic on weight loss and the potential for misuse of the drug as a cosmetic fix.
  • The author states that demand for semaglutides is rising while also mentioning that famous people like Oprah Winfrey and Elon Musk have acknowledged using Ozempic.

Deceptions

100%

Examples:

  • The author does not provide any deceptive practices in the article.

Recent Articles

GLP-1 Agonists: The New Weight-Loss Drugs with Surprising Health Benefits and Potential Side Effects

GLP-1 Agonists: The New Weight-Loss Drugs with Surprising Health Benefits and Potential Side Effects

Broke On: Tuesday, 28 May 2024 New GLP-1 agonist weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound have gained popularity for their health benefits beyond weight loss. These drugs reduce appetite and slow digestion while improving cardiovascular health and reducing the risk of diabetes and cancer. However, they come with potential side effects such as gastric issues, nausea, vomiting, muscle mass loss, osteoporosis, hair loss during rapid weight loss, and disrupted hair growth cycle.